6.
Simeonova K, Koleva A, Zlatanova A, Petkova-Yankova N, Aleksandrov H, Petkov P
. Experimental and Theoretical Study on the Homodimerization Mechanism of 3-Acetylcoumarin. Molecules. 2022; 27(21).
PMC: 9655359.
DOI: 10.3390/molecules27217228.
View
7.
Wang Y, Li Y, Cao J, Yang X, Huang J, Huang M
. Research Progress of Fluorescent Probes for Detection of Glutathione (GSH): Fluorophore, Photophysical Properties, Biological Applications. Molecules. 2024; 29(18).
PMC: 11434280.
DOI: 10.3390/molecules29184333.
View
8.
Di Stasi L
. Natural Coumarin Derivatives Activating Nrf2 Signaling Pathway as Lead Compounds for the Design and Synthesis of Intestinal Anti-Inflammatory Drugs. Pharmaceuticals (Basel). 2023; 16(4).
PMC: 10142712.
DOI: 10.3390/ph16040511.
View
9.
Feng D, Zhang A, Yang Y, Yang P
. Coumarin-containing hybrids and their antibacterial activities. Arch Pharm (Weinheim). 2020; 353(6):e1900380.
DOI: 10.1002/ardp.201900380.
View
10.
Singh A, Singh K, Kaur K, Singh A, Sharma A, Kaur K
. Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure-Activity Relationships. Biomedicines. 2024; 12(6).
PMC: 11200728.
DOI: 10.3390/biomedicines12061192.
View
11.
Kapidou E, Litinas K
. An Overview of the Synthesis of 3,4-Fused Pyrrolocoumarins of Biological Interest. Molecules. 2024; 29(12).
PMC: 11206682.
DOI: 10.3390/molecules29122748.
View
12.
MYERS R, Parker M, Grizzle W
. The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines. J Cancer Res Clin Oncol. 1994; 120 Suppl:S11-3.
DOI: 10.1007/BF01377115.
View
13.
Skarga V, Matrosov A, Nichugovskiy A, Negrebetsky V, Maslov M, Boldyrev I
. pH-Dependent Photoinduced Interconversion of Furocoumaric and Furocoumarinic Acids. Molecules. 2021; 26(9).
PMC: 8126128.
DOI: 10.3390/molecules26092800.
View
14.
Balcioglu S, Karatas M, Ates B, Alici B, Ozdemir I
. Therapeutic potential of coumarin bearing metal complexes: Where are we headed?. Bioorg Med Chem Lett. 2019; 30(2):126805.
DOI: 10.1016/j.bmcl.2019.126805.
View
15.
Liu J, Wu F, Chen L, Zhao L, Zhao Z, Wang M
. Biological evaluation of coumarin derivatives as mushroom tyrosinase inhibitors. Food Chem. 2012; 135(4):2872-8.
DOI: 10.1016/j.foodchem.2012.07.055.
View
16.
Lyapchev R, Koleva A, Koleva I, Subev K, Madzharova I, Simeonova K
. Efficient Synthesis of Fluorescent Coumarins and Phosphorous-Containing Coumarin-Type Heterocycles via Palladium Catalyzed Cross-Coupling Reactions. Molecules. 2022; 27(21).
PMC: 9654183.
DOI: 10.3390/molecules27217649.
View
17.
Suleiman M, Almalki F, Hadda T, Kawsar S, Chander S, Murugesan S
. Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents-A Mini Review. Pharmaceuticals (Basel). 2023; 16(11).
PMC: 10675815.
DOI: 10.3390/ph16111538.
View
18.
Secci D, Carradori S, Bolasco A, Chimenti P, Yanez M, Ortuso F
. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Eur J Med Chem. 2011; 46(10):4846-52.
DOI: 10.1016/j.ejmech.2011.07.017.
View
19.
El-Sawy E, Abdel-Aziz M, Abdelmegeed H, Kirsch G
. Coumarins: Quorum Sensing and Biofilm Formation Inhibition. Molecules. 2024; 29(19).
PMC: 11478192.
DOI: 10.3390/molecules29194534.
View
20.
Kornicka A, Balewski L, Lahutta M, Kokoszka J
. Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential. Pharmaceuticals (Basel). 2023; 16(12).
PMC: 10747342.
DOI: 10.3390/ph16121732.
View